A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on experiences and barriers

Respiratory Research
C C MoorM S Wijsenbeek

Abstract

In idiopathic pulmonary fibrosis (IPF), home monitoring experiences are limited, not yet real-time available nor implemented in daily care. We evaluated feasibility and potential barriers of a new home monitoring program with real-time wireless home spirometry in IPF. Ten patients with IPF were asked to test this home monitoring program, including daily home spirometry, for four weeks. Measurements of home and hospital spirometry showed good agreement. All patients considered real-time wireless spirometry useful and highly feasible. Both patients and researchers suggested relatively easy solutions for the identified potential barriers regarding real-time home monitoring in IPF.

References

Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Jun 6, 1996·Health Policy·R Brooks
Apr 8, 2011·American Journal of Respiratory and Critical Care Medicine·Ganesh RaghuUNKNOWN ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis
Apr 19, 2016·American Journal of Respiratory and Critical Care Medicine·Anne-Marie RussellToby M Maher
Jul 7, 2017·The European Respiratory Journal·Kerri A JohannsonHarold R Collard
Jan 20, 2018·The European Respiratory Journal·Catharina C MoorMarlies S Wijsenbeek
Jan 20, 2018·The European Respiratory Journal·Caroline E BroosBernt van den Blink

❮ Previous
Next ❯

Citations

Apr 24, 2020·American Journal of Respiratory and Critical Care Medicine·Catharina C MoorMarlies S Wijsenbeek
May 14, 2020·American Journal of Respiratory and Critical Care Medicine·Kerri A Johannson
Sep 29, 2020·Expert Review of Respiratory Medicine·Steven D NathanJohn L Stauffer
May 8, 2019·Journal of Personalized Medicine·Catharina C MoorMarlies S Wijsenbeek
Jun 27, 2019·Annals of the American Thoracic Society·Veronica MarcouxKerri A Johannson
Oct 1, 2019·Advances in Therapy·Eva SantermansMarlies Wijsenbeek
Nov 26, 2020·Journal of Personalized Medicine·Nynke WijbengaCatharina C Moor
Oct 20, 2020·The Lancet. Respiratory Medicine·G NakshbandiM S Wijsenbeek
Mar 29, 2021·Paediatric Respiratory Reviews·C H RichardsonS B Carr
Apr 30, 2021·Respirology : Official Journal of the Asian Pacific Society of Respirology·Alan K Y Teoh, Tamera J Corte
May 25, 2021·Clinics in Chest Medicine·Alyson W Wong, Sonye K Danoff
May 25, 2021·Clinics in Chest Medicine·Kerri A JohannsonLuca Richeldi
Jul 24, 2021·Breathe·Neeraj M Shah, Georgios Kaltsakas
Jan 10, 2021·The European Respiratory Journal·Imre NothUNKNOWN INMARK trial investigators
Aug 18, 2021·Respiratory Research·Anouk DelameillieureFabienne Dobbels
Jul 21, 2021·American Journal of Respiratory and Critical Care Medicine·Kerri I AronsonJeffrey J Swigris
Oct 8, 2021·European Respiratory Review : an Official Journal of the European Respiratory Society·Andrew KouriChung-Wai Chow
Dec 13, 2019·Respiration; International Review of Thoracic Diseases·Wim A WuytsElisabeth Bendstrup

❮ Previous
Next ❯

Related Concepts

Related Feeds

CFTR Mutant Structural Therapy

Over 1700 different mutations in the CFTR genes have been shown to cause cystic fibrosis. Here is the latest research on structural therapy for CFTR mutants.

Related Papers

American Journal of Respiratory and Critical Care Medicine
Kerri A Johannson, Christopher J Ryerson
American Journal of Respiratory and Critical Care Medicine
Wim A WuytsGeert M Verleden
American Journal of Respiratory and Critical Care Medicine
Anne-Marie Russellall authors
Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society
Yoshio Taguchi
© 2022 Meta ULC. All rights reserved